To more fully characterize the impact of SOX2 on the expression of CD133 in medulloblastoma cells, i-SOX2-DAOY cells (not exposed to Dox) were sorted into CD133-high (CD133+) and CD133-low (CD133−) populations by FACS. The gene discussed is SOX2; the disease is medulloblastoma.